Picard Medical reports Q3 EPS (19c) vs. (87c) last year

Reports Q3 revenue $1.19M vs. $881,000 last year. Patrick NJ Schnegelsberg, Chief Executive Officer of Picard Medical (PMI), Inc., commented, “The third quarter marked a pivotal moment for the company with the successful completion of its initial public offering in September. The IPO strengthened the balance sheet by retiring convertible debt, providing new capital to accelerate research, development, and commercial expansion across SynCardia’s life-saving artificial heart platform.”